Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 250,438 shares at $3.26 ($816K) on 2013-05-15, disclosed to the SEC on 2013-05-17.
Scheduled sale ($816k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.26 | 35,000 | $114K | 14.0% |
| 2 | $3.26 | 215,438 | $702K | 86.0% |
| Total | $3.26 avg | 250,438 | $816K | 100% |
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |